Microsoft
MSFT
MARA Holdings
MARA
Coinbase
COIN
Apple
AAPL
Meta Platforms
META
US Stock MarketDetailed Quotes
IONS Ionis Pharmaceuticals
- 37.660
- -0.330-0.87%
Trading Dec 12 10:48 ET
5.95BMarket Cap-15.43P/E (TTM)
38.171High37.450Low232.58KVolume38.000Open37.990Pre Close8.79MTurnover0.15%Turnover RatioLossP/E (Static)157.90MShares54.44552wk High8.98P/B5.90BFloat Cap33.33052wk Low--Dividend TTM156.65MShs Float86.582Historical High--Div YieldTTM1.90%Amplitude2.500Historical Low37.798Avg Price1Lot Size
About Ionis Pharmaceuticals Company
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Company Profile
SymbolIONS
Company NameIonis Pharmaceuticals
Listing DateApr 17, 1991
Issue Price57.56
Founded1989
CEODr. Brett P. Monia, PhD
MarketNASDAQ
Employees927
Fiscal Year Ends12-31
Address2855 Gazelle Court
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92010
Phone1-760-931-9200
Websitehttp://www.ionis.com
Company Executives
- Name
- Position
- Salary
- Dr. Brett P. Monia, PhD
- Chief Executive Officer and Director
- 12.50M
- Eugene Schneider
- Executive Vice President and Chief Clinical Development and Operations Officer
- --
- Dr. C. Frank Bennett,PhD
- Executive Vice President and Chief Scientific Officer
- --
- Elizabeth L. Hougen
- Executive Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
- 2.89M
- Patrick R. O'Neil, Esq.
- Chief Legal Officer, General Counsel and Corporate Secretary
- --
- Joseph T. Baroldi
- Executive Vice President and Chief Business Officer
- --
- Dr. Richard S. Geary,PhD
- Executive Vice President and Chief Development Officer
- 2.56M
- Brian Birchler
- Executive Vice President, Corporate and Development Operations
- --
- Kyle Jenne
- Executive Vice President, Commercial
- --
- Eric E. Swayze, PhD
- Executive Vice President, Research
- 2.56M
- Dr. Joseph Loscalzo, M.D.,PhD
- Chairman of the Board
- 568.04K
- B. Lynne Parshall, Esq.,J.D.
- Director
- 538.04K
- Joseph Klein, III
- Independent Director
- 542.04K
- Michael J. Yang
- Independent Director
- 363.05K
- Dr. Michael Hayden
- Independent Director
- 528.04K
- Allene M. Diaz
- Independent Director
- 530.04K
- Joseph H. Wender
- Lead Independent Director
- 598.04K
- Joan E. Herman
- Independent Director
- 540.04K
- Dr. Spencer R. Berthelsen,M.D.
- Independent Director
- 548.04K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.